Exact Mass: 471.1999
Exact Mass Matches: 471.1999
Found 203 metabolites which its exact mass value is equals to given mass value 471.1999
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Dabigatran
C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C180619 - Direct Oral Anticoagulant C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C173066 - Direct Thrombin Inhibitor D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors D006401 - Hematologic Agents > D000925 - Anticoagulants > D000991 - Antithrombins COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Dabigatran
C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C180619 - Direct Oral Anticoagulant C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C173066 - Direct Thrombin Inhibitor D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors D006401 - Hematologic Agents > D000925 - Anticoagulants > D000991 - Antithrombins COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
3-[3-Tert-butylsulfanyl-1-[(4-chlorophenyl)methyl]-5-propan-2-ylindol-2-yl]-2,2-dimethylpropanoic acid
D004791 - Enzyme Inhibitors > D016859 - Lipoxygenase Inhibitors
1H-Indole-2-propanoic acid, 1-[(4-chlorophenyl)methyl]-3-[(1,1-dimethylethyl)thio]-Alpha,Alpha-dimethyl-5-(1-methylethyl)- [CAS]
Ala His Met Asn
Ala His Asn Met
Ala Met His Asn
Ala Met Asn His
Ala Asn His Met
Ala Asn Met His
Cys Gly His Arg
Cys Gly Arg His
Cys His Gly Arg
Cys His Asn Val
Cys His Arg Gly
Cys His Val Asn
Cys Asn His Val
Cys Asn Val His
Cys Arg Gly His
Cys Arg His Gly
Cys Val His Asn
Cys Val Asn His
Gly Cys His Arg
Gly Cys Arg His
Gly His Cys Arg
Gly His Met Gln
Gly His Gln Met
Gly His Arg Cys
Gly Met His Gln
Gly Met Gln His
Gly Gln His Met
Gly Gln Met His
Gly Arg Cys His
Gly Arg His Cys
His Ala Met Asn
His Ala Asn Met
His Cys Gly Arg
His Cys Asn Val
His Cys Arg Gly
His Cys Val Asn
His Gly Cys Arg
His Gly Met Gln
His Gly Gln Met
His Gly Arg Cys
His Met Ala Asn
His Met Gly Gln
His Met Asn Ala
His Met Gln Gly
His Asn Ala Met
His Asn Cys Val
His Asn Met Ala
His Asn Thr Thr
His Asn Val Cys
His Gln Gly Met
His Gln Met Gly
His Gln Ser Thr
His Gln Thr Ser
His Arg Cys Gly
His Arg Gly Cys
His Ser Gln Thr
His Ser Thr Gln
His Thr Asn Thr
His Thr Gln Ser
His Thr Ser Gln
His Thr Thr Asn
His Val Cys Asn
His Val Asn Cys
Met Ala His Asn
Met Ala Asn His
Met Gly His Gln
Met Gly Gln His
Met His Ala Asn
Met His Gly Gln
Met His Asn Ala
Met His Gln Gly
Met Asn Ala His
Met Asn His Ala
Met Gln Gly His
Met Gln His Gly
Asn Ala His Met
Asn Ala Met His
Asn Cys His Val
Asn Cys Val His
Asn His Ala Met
Asn His Cys Val
Asn His Met Ala
Asn His Thr Thr
Asn His Val Cys
Asn Met Ala His
Asn Met His Ala
Asn Asn Pro Gln
Asn Asn Gln Pro
Asn Pro Asn Gln
Asn Pro Gln Asn
Asn Gln Asn Pro
Asn Gln Pro Asn
Asn Thr His Thr
Asn Thr Thr His
Asn Val Cys His
Asn Val His Cys
Pro Asn Asn Gln
Pro Asn Gln Asn
Pro Gln Asn Asn
Gln Gly His Met
Gln Gly Met His
Gln His Gly Met
Gln His Met Gly
Gln His Ser Thr
Gln His Thr Ser
Gln Met Gly His
Gln Met His Gly
Gln Asn Asn Pro
Gln Asn Pro Asn
Gln Pro Asn Asn
Gln Ser His Thr
Gln Ser Thr His
Gln Thr His Ser
Gln Thr Ser His
Arg Cys Gly His
Arg Cys His Gly
Arg Gly Cys His
Arg Gly His Cys
Arg His Cys Gly
Arg His Gly Cys
Ser His Gln Thr
Ser His Thr Gln
Ser Gln His Thr
Ser Gln Thr His
Ser Thr His Gln
Ser Thr Gln His
Thr His Asn Thr
Thr His Gln Ser
Thr His Ser Gln
Thr His Thr Asn
Thr Asn His Thr
Thr Asn Thr His
Thr Gln His Ser
Thr Gln Ser His
Thr Ser His Gln
Thr Ser Gln His
Thr Thr His Asn
Thr Thr Asn His
Val Cys His Asn
Val Cys Asn His
Val His Cys Asn
Val His Asn Cys
Val Asn Cys His
Val Asn His Cys
MK 886
ETHYL 5-(2,4-BIS(BENZYLOXY)-5-ISOPROPYLPHENYL)ISOXAZOLE-3-CARBOXYLATE
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclohexylamino)-2-oxoethyl]-7-methyl-N-(2-methylphenyl)- (9CI)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclohexylamino)-2-oxoethyl]-7-methyl-N-(3-methylphenyl)- (9CI)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclohexylamino)-2-oxoethyl]-7-methyl-N-(4-methylphenyl)- (9CI)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclopentylamino)-2-oxoethyl]-N-(2,3-dimethylphenyl)-7-methyl- (9CI)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclopentylamino)-2-oxoethyl]-N-(2,4-dimethylphenyl)-7-methyl- (9CI)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclopentylamino)-2-oxoethyl]-N-(2,5-dimethylphenyl)-6-methyl- (9CI)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclopentylamino)-2-oxoethyl]-N-(2,5-dimethylphenyl)-7-methyl- (9CI)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclopentylamino)-2-oxoethyl]-N-(2-ethylphenyl)-7-methyl- (9CI)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclopentylamino)-2-oxoethyl]-N-(3,5-dimethylphenyl)-7-methyl- (9CI)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclopentylamino)-2-oxoethyl]-N-(4-ethylphenyl)-6-methyl- (9CI)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclopentylamino)-2-oxoethyl]-N-(4-ethylphenyl)-7-methyl- (9CI)
LDS 751 dye
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes
2-[3a-[1-(furan-3-yl)-5,8a-dimethyl-3-oxo-4,6,7,8-tetrahydro-1H-isochromen-6-yl]-2,2-dimethyl-6-oxo-3,4,7,7a-tetrahydrofuro[3,2-c]pyran-3-yl]acetate
3-ethyl-2-[(E)-2-[(E)-(3-ethyl-5,6-dimethyl-1,3-benzothiazol-2-ylidene)methyl]but-1-enyl]benzo[g][1,3]benzothiazol-3-ium
(4R,5R)-5-(2-azidophenyl)-2-[4-(3-hydroxypropoxy)phenyl]-4-(phenylmethyl)-5H-oxazole-4-carboxamide
N-[(5R,6S,9S)-5-methoxy-8-(2-methoxy-1-oxoethyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(5R,6R,9S)-5-methoxy-8-(2-methoxy-1-oxoethyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
(2R,3R,3aS,9bS)-N-(2,3-dihydro-1H-inden-2-yl)-3-(hydroxymethyl)-6-oxo-1-[oxo(2-pyrazinyl)methyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
N-[(5R,6S,9R)-5-methoxy-8-(2-methoxyacetyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(5S,6R,9R)-5-methoxy-8-(2-methoxyacetyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(5S,6R,9S)-5-methoxy-8-(2-methoxyacetyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(5R,6R,9R)-5-methoxy-8-(2-methoxy-1-oxoethyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(5S,6S,9S)-5-methoxy-8-(2-methoxy-1-oxoethyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]-1,3-benzodioxole-5-carboxamide
N-[2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]-1,3-benzodioxole-5-carboxamide
N-[2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]-1,3-benzodioxole-5-carboxamide
2-[(2R,5R,6S)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-methoxyphenyl)methyl]acetamide
2-[(2R,5R,6R)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-methoxyphenyl)methyl]acetamide
2-[(2S,5R,6R)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-methoxyphenyl)methyl]acetamide
N-[(5S,6S,9R)-5-methoxy-8-(2-methoxy-1-oxoethyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]-1,3-benzodioxole-5-carboxamide
N-[2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]-1,3-benzodioxole-5-carboxamide
N-[2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]-1,3-benzodioxole-5-carboxamide
N-[2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]-1,3-benzodioxole-5-carboxamide
N-[2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]-1,3-benzodioxole-5-carboxamide
2-[(2S,5R,6S)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-methoxyphenyl)methyl]acetamide
2-[(2R,5S,6R)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-methoxyphenyl)methyl]acetamide
2-[(2S,5S,6S)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-methoxyphenyl)methyl]acetamide
2-[(2R,5S,6S)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-methoxyphenyl)methyl]acetamide
(2S,3S,3aR,9bR)-N-(2,3-dihydro-1H-inden-2-yl)-3-(hydroxymethyl)-6-oxo-1-[oxo(2-pyrazinyl)methyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
MK886
D004791 - Enzyme Inhibitors > D016859 - Lipoxygenase Inhibitors
Z-Gly-Arg-Thiobenzyl ester
Z-Gly-Arg-Thiobenzyl ester is a chromogenic substrate for plasmogen-activated serine proteases[1].